| Yoni Tyson, LPC | |
|
700 University City Blvd, Blacksburg, VA 24060-2706 | |
| (540) 961-8300 | |
| (540) 961-8465 |
| Full Name | Yoni Tyson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 700 University City Blvd, Blacksburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083200802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 0701010143 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Yoni Tyson, LPC 700 University City Blvd, Blacksburg, VA 24060-2706 Ph: (540) 961-8300 | Yoni Tyson, LPC 700 University City Blvd, Blacksburg, VA 24060-2706 Ph: (540) 961-8300 |
News Archive
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.
A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.
Drugs for HIV have become adept at suppressing infection, but they still can't eliminate it. That's because the medication in these pills doesn't touch the virus' hidden reserves, which lie dormant within infected white blood cells. Unlock the secrets of this pool of latent virus, scientists believe, and it may become possible to cure - not just control - HIV.
Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
› Verified 6 days ago
Katherine Ann Flaherty, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 University City Blvd, Blacksburg, VA 24060 Phone: 540-961-8300 | |
Deana Joanne Hinson, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Hubbard St Ste C, Blacksburg, VA 24060 Phone: 540-381-6215 Fax: 540-951-8733 | |
Minna R Jackson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Ardmore St Ste 304, Blacksburg, VA 24060 Phone: 276-613-4273 | |
Anne Hayes Giles, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2001 S Main St Ste 207c, Blacksburg, VA 24060 Phone: 540-808-6334 | |
Dr. Harvey Michael Barker, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 305 Washington St Sw, Blacksburg, VA 24060 Phone: 540-443-9607 Fax: 540-552-0119 | |
Joy Badalis, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 University City Blvd, Blacksburg, VA 24060 Phone: 540-961-8300 Fax: 540-961-8465 | |
Sivonna Stringham, Counselor Medicare: Not Enrolled in Medicare Practice Location: 106 Southpark Dr Ste C, Blacksburg, VA 24060 Phone: 855-284-7483 |